Cargando…
Silencing of FOS-like antigen 1 represses restenosis via the ERK/AP-1 pathway in type 2 diabetic mice
Restenosis is a major limiting factor for a successful outcome in type 2 diabetes (T2D) patients undergoing percutaneous coronary intervention (PCI). The aim of this study is to explore the role and regulatory mechanism of FOS-like antigen 1 (FOSL1) in restenosis in T2D. A T2D with restenosis mouse...
Autores principales: | Zhou, Chaoxi, Wang, Fujun, Ma, Hongfang, Xing, Na, Hou, Lin, Du, Yaping, Ding, Haixia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669130/ https://www.ncbi.nlm.nih.gov/pubmed/34881661 http://dx.doi.org/10.1177/14791641211058855 |
Ejemplares similares
-
Bone cell differentiation and the role of Fos/AP-1 proteins
por: Wagner, E, et al.
Publicado: (2003) -
Fast regulation of AP-1 activity through interaction of lamin A/C, ERK1/2, and c-Fos at the nuclear envelope
por: González, José María, et al.
Publicado: (2008) -
Gfi1-Mediated Repression of c-Fos, Egr-1 and Egr-2, and Inhibition of ERK1/2 Signaling Contribute to the Role of Gfi1 in Granulopoiesis
por: Zhang, Yangyang, et al.
Publicado: (2019) -
Regulation of osteosarcoma cell lung metastasis by the c-Fos/AP-1 target FGFR1
por: Weekes, Daniel, et al.
Publicado: (2015) -
Trans-repressor activity of nuclear glycosaminoglycans on Fos and Jun/AP-1 oncoprotein-mediated transcription
Publicado: (1992)